COMPARATIVE EFFECTIVENESS OF USTEKINUMAB VERSUS VEDOLIZUMAB IN TUMOR NECROSIS FACTOR INHIBITOR-EXPOSED PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS

Category Primary study
JournalJournal of Pediatric Gastroenterology and Nutrition
Year 2022
This article has no abstract
Epistemonikos ID: 13ef13a157e89636f11329185d69299aefd84f57
First added on: Feb 15, 2025